Hamzullah Khan, Shahtaj khan, Faridullah Shah


Background: Diabetic co-morbidities in recent past pandemic were becoming a challenge to the clinicians. COVID-19 is a respiratory infectious disease caused by SARS-COV-2 virus. World health organization declared COVID-19 pandemic in Feb 2020. The objective of this study was to determine the severity of inflammation in COVID-19 patients with diabetic co-morbidities in a hospital based study.

Material and methods: This descriptive study covering 176 patients was conducted in Hayatabad Medical Complex Peshawar from 25 April 2021 to 21st October 2021. Receiver operating characteristics (ROC) curve was used as statistical tool to determine the relationship of clinical sensitivity of different inflammatory markers in diabetic COVID-19 patients to predict the outcome. Post-stratification Chi square test was used at 5% level of significance.

Results: Out of 176 patients, 149 (84.7%) patients were discharged satisfactorily while 27 patients expired during hospitalization. Mean with SD for age was 53.28±13.73 years, for D dimer was 13.14±2.61 ug/ml and for CRP was 16.73+11.78 mg/l. Median of serum Ferritin was 1120 ng/ml. There was a significantly higher inflammatory markers values of D-dimer (p=0.001 and ferritin (p=0.001) in diabetic versus non diabetic COVID Patients. D-Dimer was main decisive prognostic indicator in diabetics with COVID-19 to predict mortality/worst outcome with an Area under Curve (AUC) of (0.929 95%CI 0.88-0.96) followed by Serum ferritin (0.868 95%CI 0.78-0.95). There was a significant association of Diabetes with Mortality (p<0.001) in COVID-19 patients.

Conclusion: The clinical sensitivity of d-dimer and ferritin toward mortality in COVID-19 patients with diabetic co-morbidities is significantly high in our population. Diabetes alone has a significant positive association with worst outcome in covid-19.


COVID-19; Ferritin; Mortality; Diabetes mellitus.

Full Text:



World Health Organization. 2019-nCoV outbreak is an emergency of international concern. 2020. (access Feb 8,2020). , Retrieved Aug 9,2022.

"Coronavirus in Pakistan - Confirmed Cases". . Retrieved Aug 9 , 2022.

Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol 2001;38:77-82.

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 73 Google Scholar

Epidemiology Working Group for Ncip Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol 2020;41(2):145-151.

Al-Tawfiq JA, Hinedi K, J. Ghandour J, Khairalla H, Musleh S, Ujayli A, et al.Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis 2014;59:160-165.

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the seattle region - case series NEJM 2020:10.1056/NEJMoa2004500.

Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care 2018;41(3):513-521.

Mishra Y, Pathak BK, Mohakuda SS,Tilak TVS, Sen S, Harikrishnan P et al. Relation of D-dimer levels of COVID-19 patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020;14:1927e193.

Guo w, Li M, Dong Y, Zhao H, Zhang Z, Tian C et al. Diabetes is a risk factor for the progression and prognosis ofCOVID-19. Diabetes Metab Res Rev 2020;36:e3319.

Asghar MS, Haider-Kazmi SJ, Khan NA, Akram M, Hassan M, et al. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country. Cureus. 2020;12(8):9575.

Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med 2020;9:1417.

Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemostasis. 2020;18:1324.

Domingueti CP, Dusse LMSA, Carvalho MDG, De Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabet Complicat 2016;30:738.

Onder G, Rezza G, Brusaferro S. Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775-76.

lshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLOS One 2020; 15(8):e0238160.

Khan K, Khan H, Khan S, Khan MF, Ali M, Usman M. Comparison of Hematological and Inflammatory Markers to Predict Outcome in Covid-19 in 1st and 4th Wave. J Gandhara Med Dent Sci 2022; 9(3):44-50.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-1062.



  • There are currently no refbacks.

Copyright (c) 2022 Hamzullah Khan, Shahtaj Khan, Faridullah Shah.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Gomal Medical College, Daraban Road, Dera Ismail Khan, Pakistan

ISSN: 1819-7973, e-ISSN: 1997-2067


Phone: +92-966-747373

Scimago Journal & Country Rank